08:00 , Feb 10, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Excision repair cross-complementing group 3 (ERCC3; XPB) In vitro studies suggest that the XPB inhibitor triptolide could help treat cancer. In HeLa cells, triptolide...